Browsing by Yonsei Author : Chung, Hyun Cheol

eperson profile image
Name:
Chung, Hyun Cheol [정현철]
orcid http://orcid.org/0000-0002-0920-9471
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7404006815)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 397

This table browses all dspace content
Issue DateTitleJournal Title
2022PD-L1 expression and overall survival in Asian and western patients with gastric cancerFUTURE ONCOLOGY
2022Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors CANCERS
2021The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer NATURE
2021Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion studyLANCET ONCOLOGY
2021Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient TumorsCLINICAL CANCER RESEARCH
2021Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancerCELLULAR ONCOLOGY
2021Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer CANCER MEDICINE
2021Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 GASTRIC CANCER
2021Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensBREAST CANCER RESEARCH AND TREATMENT
2021Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade ResponsesHEPATOLOGY
2021Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations INVESTIGATIONAL NEW DRUGS
2021Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma ANNALS OF ONCOLOGY
2021Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in AsiaTARGETED ONCOLOGY
2021Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab GASTRIC CANCER
2021Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population GUT
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2021Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10 CLINICAL CANCER RESEARCH
2021MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma FUTURE ONCOLOGY
2021Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea CANCER RESEARCH AND TREATMENT
2021Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib TrialCLINICAL CANCER RESEARCH
2021First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 FUTURE ONCOLOGY
2021Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaJOURNAL OF HEPATOLOGY
2021Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysisEUROPEAN JOURNAL OF CANCER
2021p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancerBIOCHEMICAL PHARMACOLOGY
2020Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells Genomics & Informatics
2020Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768IMOLECULAR CANCER THERAPEUTICS
2020Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studiesINTERNATIONAL JOURNAL OF CANCER
2020Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 studyLANCET ONCOLOGY
2020Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialJAMA ONCOLOGY
2020Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2020S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trialLANCET ONCOLOGY
2020Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer MOLECULAR THERAPY-ONCOLYTICS
2020Waun Ki Hong, MD, D.M.Sc (Hon) (1942-2019): A Mentor Who Left Behind a Legacy for Generations to Come YONSEI MEDICAL JOURNAL
2020Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer CLINICAL CANCER RESEARCH
2020Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric CancerNEW ENGLAND JOURNAL OF MEDICINE
2020A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data GASTRIC CANCER
2020Glutathione 주사에 의해 유발된 치명적인 천식발작 1예 ALLERGY ASTHMA & RESPIRATORY DISEASE
2020Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 StudiesJOURNAL OF THORACIC ONCOLOGY
2020Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma CLINICAL CANCER RESEARCH
2020Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer GASTRIC CANCER
2020Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2020Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot studySUPPORTIVE CARE IN CANCER
2020Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 StudyJOURNAL OF CLINICAL ONCOLOGY
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2019Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerEUROPEAN JOURNAL OF CANCER
2019Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancerGASTRIC CANCER
2019Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2019Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical TrialJAMA Network Open
2019Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2019Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Gastric Cancer

Browse

Links